Antibody evasion and receptor binding of SARS-CoV-2 RW.1.1

Antibody 3CF5 neutralizes historical and emerging H5Nx influenza viruses by targeting a conserved non-receptor-binding hemagglutinin epitope
Huan Liang, Chuanying Niu, Yuanyi Cheng +16
Cell Reports30 Oct 2026Peer-reviewedCC BY-NC-ND 4.0General biologyCrossref
Increased receptor binding capability of the SARS-CoV-2 saltational variant PJ.2.1
P. He, B. Li, C. Guo +5
bioRxiv3 Sep 2026PreprintCC BY-NCFull textMicrobiologybioRxiv
The SARS-CoV-2 spike receptor-binding domain has evolved decreased inherent antigenicity in humans
C. Jacob-Dolan, J. B. Boonyaratanakornkit, J. D. Bloom
bioRxiv15 Oct 2026PreprintCC BYFull textMicrobiologybioRxiv
Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity
K. Y. Choi, Y. Qin, N. El-Hamdi +1
bioRxiv28 Oct 2026PreprintAll rights reservedFull textMicrobiologybioRxiv
Modulation of gp130 Cytokine Receptor Family by Herpes Simplex Virus 1 as a Strategy for Immune Evasion?
K. Foster-Lemieur, S. M. Suma, M. Ajith +1
bioRxiv6 Oct 2026PreprintAll rights reservedFull textMicrobiologybioRxiv

Cite

BibTeX

@misc{daniel2026antibody,
  title = {{Antibody evasion and receptor binding of SARS-CoV-2 RW.1.1}},
  author = {K. Daniel and H. Hong and C.-Y. Huang and A. Gordon and Y. Guo and D. D. Ho and I. A. Mellis},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.10.750645},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.10.750645v1},
}

RIS

TY  - UNPB
TI  - Antibody evasion and receptor binding of SARS-CoV-2 RW.1.1
AU  - K. Daniel
AU  - H. Hong
AU  - C.-Y. Huang
AU  - A. Gordon
AU  - Y. Guo
AU  - D. D. Ho
AU  - I. A. Mellis
PY  - 2026
DA  - 2026/09/10
PB  - bioRxiv
DO  - 10.64898/2026.09.10.750645
UR  - https://www.biorxiv.org/content/10.64898/2026.09.10.750645v1
ER  -

Related

Cite